Five undervalued stocks including CleanSpark, Sanofi, Uber, Macy's and e.l.f. Beauty combine discounted valuations with strong analyst buy ratings for 2026.

Shifting gears, it turns out that 2025 was a slightly off year for drug approvals by the US Food and Drug Administration. A ...

As demand accelerates for faster, more accessible diagnostic imaging across the Middle East and Africa (MEA), Cairo-based ...

Dow Jones Top Company Headlines at 5 PM ET: Tesla Under Investigation by U.S. Regulator for Model 3 Door Release Defects | Nike ... Tesla Under Investigation by U.S. Regulator for Model 3 Door Release ...

A relatively quiet session on Wall Street before Christmas saw stocks hitting all-time highs, with more signs the jobs market is not quickly deteriorating supporting bets on a soft economic landing.

A relatively quiet session on Wall Street before Christmas saw stocks hitting all-time highs, with more signs the jobs market is not quickly deteriorating supporting bets on a soft economic landing.

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

The acquisition of Alimera Sciences, Inc., in 2024 added a growing and durable franchise, Iluvien for (diabetic macular edema ...

Jollibee Foods Corp plans to spin off its international operations and list the new unit as an independent company on a U.S.

Jollibee Foods Corp. announces plans to spin off its international operations for a U.S. listing by 2027 while maintaining ...

Deal follows acquisitions of Vicebio and BluePrint Medicines Sanofi keen to diversify growth beyond asthma drug Dupixent Expects to finalise Dynavax deal in Q1 2026 Dynavax shares soar 39% The ...